Hotspot mutations in common oncogenes are infrequent in nasopharyngeal carcinoma

作者: NING JIANG , NA LIU , FAN YANG , QIMING ZHOU , RUIXUE CUI

DOI: 10.3892/OR.2014.3376

关键词: CarcinomaNasopharyngeal carcinomaCancer researchCarcinogenesisBiologyMutantGeneGene mutationOncogeneGeneticsCell cycle

摘要: Oncogene mutations contribute to carcinogenesis and can provide potential therapeutic targets for clinical anticancer management. However, oncogene mutation patterns in nasopharyngeal carcinoma (NPC) have yet be fully elucidated. To gain insight into NPC, a high-throughput OncoCarta panel assay was used determine 238 hotspot across 19 common oncogenes 8 NPC cell lines 160 patient samples from southern China. Statistical analyses were further conducted identify associations between selected clinicopathological characteristics. In total, we identified 24 11 17 (10.6%) patients. Four patients exhibited at least one oncogene. We also PIK3CA H1047R mutant 7 lines. addition, showed no correlation with either risk habits (smoking drinking) or other characteristics except TNM stage. KIT associated poorer overall relapse-free survival. Furthermore, together age N stage independent prognostic factors NPC. Taken together, the present study is first report on multiple found that are infrequent The lack of requires comprehensive characterization gene developing new future.

参考文章(55)
S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok, J. Clements, A. Menzies, J.W. Teague, P.A. Futreal, M.R. Stratton, The Catalogue of Somatic Mutations in Cancer (COSMIC). Current protocols in human genetics. ,vol. 57, ,(2008) , 10.1002/0471142905.HG1011S57
Laleh Shayesteh, Yiling Lu, Wen-Lin Kuo, Russell Baldocchi, Tony Godfrey, Colin Collins, Daniel Pinkel, Bethan Powell, Gordon B. Mills, Joe W. Gray, PIK3CA is implicated as an oncogene in ovarian cancer Nature Genetics. ,vol. 21, pp. 99- 102 ,(1999) , 10.1038/5042
Marisa Pearce, Amy Cullinan, Grant Hogg, Dana Hosseini, Mathias Ehrich, Mutation profiling in tumor samples using the Sequenom OncoCarta|[trade]| Panel Nature Methods. ,vol. 6, ,(2009) , 10.1038/NMETH.F.254
Marcia S Brose, Patricia Volpe, Michael Feldman, Madhu Kumar, Irum Rishi, Renee Gerrero, Eugene Einhorn, Meenhard Herlyn, John Minna, Andrew Nicholson, Jack A Roth, Steven M Albelda, Helen Davies, Charles Cox, Graham Brignell, Philip Stephens, P Andrew Futreal, Richard Wooster, Michael R Stratton, Barbara L Weber, None, BRAF and RAS mutations in human lung cancer and melanoma Cancer Research. ,vol. 62, pp. 6997- 7000 ,(2002)
Francesco Caponigro, Francesco Longo, Franco Ionna, Francesco Perri, Treatment approaches to nasopharyngeal carcinoma: a review. Anti-Cancer Drugs. ,vol. 21, pp. 471- 477 ,(2010) , 10.1097/CAD.0B013E328337160E
Angela Bik-Yu Hui, Kwok-Wai Lo, Sing-Fai Leung, Peter Teo, Michael K.F. Fung, K.F. To, Nathalie Wong, Peter H.K. Choi, Joseph C.K. Lee, Dolly P. Huang, Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. International Journal of Cancer. ,vol. 82, pp. 498- 503 ,(1999) , 10.1002/(SICI)1097-0215(19990812)82:4<498::AID-IJC5>3.0.CO;2-S
Alberto Bardelli, Pasi A Jänne, The road to resistance: EGFR mutation and cetuximab Nature Medicine. ,vol. 18, pp. 199- 200 ,(2012) , 10.1038/NM.2646
Raphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, Maryou B Lambros, Alan MacKay, Roger A' Hern, Arnaud Gauthier, Vidya Pawar, Pierre-Emanuel Colombo, Frances Daley, Rachael Natrajan, Eric Ward, Gaëtan MacGrogan, Flavie Arbion, Patrick Michenet, Britta Weigelt, Anne Vincent-Salomon, Jorge S Reis-Filho, Immunophenotypic and genomic characterization of papillary carcinomas of the breast The Journal of Pathology. ,vol. 226, pp. 427- 441 ,(2012) , 10.1002/PATH.3032
Pei-Yu Huang, Ming-Huang Hong, Xing Zhang, Hai-Qiang Mai, Dong-Hua Luo, Li Zhang, C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines Chinese Journal of Cancer. ,vol. 29, pp. 131- 135 ,(2010) , 10.5732/CJC.009.10411